Sponsors (81)
The bill expands no‑cost access to recommended vaccines and freezes certain coverage rules through 2029 to boost vaccination and reduce short‑term uncertainty, but shifts costs onto insurers/employers and states and leaves post‑2029 coverage and some billing details uncertain.
People with employer-sponsored and individual health plans, Medicaid and CHIP-enrolled children, and other covered beneficiaries gain no-cost access to ACIP-recommended vaccines (no copays or deductibles) for plan years through Dec 31, 2029, reducing financial barriers to vaccination and likely increasing immunization rates and preventing disease.
Seniors and other Medicare beneficiaries get clearer short-term guidance because the bill freezes how ACIP recommendations are treated for Medicare Part D/covered vaccine determinations as of Oct 25, 2024, reducing immediate coverage uncertainty.
Low- and middle-income families are less likely to face vaccine-related out-of-pocket costs during the covered period, which supports public-health goals and can reduce downstream healthcare use from preventable illness.
Insurers and employers must absorb short-term costs to cover recommended vaccines without cost-sharing, which could be passed on as higher premiums, reduced benefits, or other cost-shifting affecting workers and taxpayers.
Coverage protections are time-limited (expire Dec 31, 2029), creating significant uncertainty for patients, providers, and payers about vaccine access and costs after the sunset date.
The federal requirement for benchmark or benchmark-equivalent plans may reduce state flexibility and force state budget or benefit adjustments to comply, straining state health program finances.
Based on analysis of 2 sections of legislative text.
Requires group and individual health plans to cover ACIP-recommended vaccines without cost-sharing for plan years beginning on or after enactment through Dec 31, 2029 (with a minimum-interval exception).
Introduced September 18, 2025 by Frank Pallone · Last progress September 18, 2025
Requires group health plans and health insurance issuers in both the group and individual markets to cover, with no cost-sharing, immunizations that had an ACIP recommendation for the relevant person as of October 25, 2024 (and updates delivered via FDA-approved BLA supplements), for plan years beginning on or after enactment through December 31, 2029. The rule excludes doses given during a required minimum interval and is implemented by adding a new preventive-services requirement to the Public Health Service Act and by updating cross-references that apply to ERISA-covered plans and other regulated issuers.